Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Intracranial atherosclerotic disease: epidemiology, imaging, treatment and prognosis, volume II.

Frontiers in neurology·2023
Same author

Editorial: Intracranial Atherosclerotic Disease: Epidemiology, Imaging, Treatment and Prognosis.

Frontiers in neurology·2021
Same author

Real-world stent retriever thrombectomy for acute ischemic stroke beyond 6 hours of onset: analysis of the NASA and TRACK registries.

Journal of neurointerventional surgery·2018
Same author

North American Solitaire Stent Retriever Acute Stroke registry: post-marketing revascularization and clinical outcome results.

Journal of neurointerventional surgery·2018
Same author

Clinical and Angiographic Outcomes with the Combined Local Aspiration and Retriever in the North American Solitaire Stent-Retriever Acute Stroke (NASA) Registry.

Interventional neurology·2018
Same author

First Pass Effect: A New Measure for Stroke Thrombectomy Devices.

Stroke·2018

Related Experiment Video

Updated: May 31, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Intra-arterial therapy for acute ischemic stroke.

Alex Abou-Chebl1

  • 1Department of Neurology, University of Louisville School of Medicine, Louisville, KY 40202, USA. a0abou03@louisville.edu

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|July 1, 2011
PubMed
Summary

Intra-arterial therapy (IAT) offers advanced stroke treatment by mechanically or chemically dissolving clots. While effective in many cases, clear guidelines and randomized trials are needed to define its role compared to other stroke therapies.

More Related Videos

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
14:53

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

Related Experiment Videos

Last Updated: May 31, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia
14:53

Intra-Arterial Delivery of Neural Stem Cells to the Rat and Mouse Brain: Application to Cerebral Ischemia

Published on: June 26, 2020

Area of Science:

  • Neurology
  • Interventional Cardiology
  • Vascular Surgery

Background:

  • Acute ischemic stroke requires rapid reperfusion to minimize brain damage.
  • Intra-arterial therapy (IAT) is an endovascular approach for clot removal in stroke patients.
  • IAT serves as an alternative or adjunct to intravenous tissue plasminogen activator (tPA), especially for extended time windows or contraindications.

Purpose of the Study:

  • To summarize the current state of intra-arterial therapy for acute ischemic stroke.
  • To highlight the effectiveness of modern IAT in achieving recanalization.
  • To identify the need for further research, particularly randomized trials, to establish IAT's definitive role.

Main Methods:

  • Review of endovascular catheter-based techniques for clot disruption.
  • Discussion of IAT in conjunction with or as an alternative to intravenous tPA.
  • Analysis of patient selection criteria, including large artery occlusions and advanced imaging techniques like penumbra assessment.

Main Results:

  • IAT utilizes mechanical disruption, local thrombolytics, or both to achieve recanalization.
  • Modern catheters enable recanalization in approximately 80% of treated patients.
  • Recanalization rates are associated with improved clinical outcomes.

Conclusions:

  • IAT is a viable option for acute ischemic stroke, particularly for large artery occlusions outside the tPA window.
  • Despite high recanalization rates, robust randomized trial data are lacking to compare IAT with tPA or standard care.
  • Further research is needed to clarify optimal patient selection and treatment guidelines for IAT.